Patents

US 12564617 B2: Methods for modulating macrophage activity

Granted
2026-03-03
Filed
2021-09-17 application 17478042
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Methods according to certain embodiments include contacting a macrophage with a mannose receptor (CD206) binding agent in a manner sufficient to modulate activity of the macrophage. Methods for converting a phenotype of a macrophage from an M2 phenotype to an M1 phenotype are also provided. Methods for inhibiting growth of a CD206-expressing cell as well as methods for treating a subject for a neoplastic condition (e.g., cancer) or a condition associated with chronic inflammation are described. Immuno-modulating peptides suitable for use in the subject methods are also presented.

Source: PTBLXML, file of 2026-03-03 (ipgb20260303.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Riptide Bioscience, Inc. 9 patentsUS company or organizationVallejo, CAPTBLXML, file of 2026-03-03

Inventors

InventorPlacePatentsPerson pageSource
Jesse JaynesAuburn, ALPTBLXML, file of 2026-03-03
Henry Wilfred LopezNapa, CA9PTBLXML, file of 2026-03-03
George R. MartinRockville, MD21PTBLXML, file of 2026-03-03
Clayton YatesAuburn, AL7PTBLXML, file of 2026-03-03
Balasubramanyam KaranamAuburn, ALPTBLXML, file of 2026-03-03

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/08PTBLXML, file of 2026-03-03
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PTBLXML, file of 2026-03-03
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0645PTBLXML, file of 2026-03-03

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-05-20Assignment
Assignment of assignor's interest
KARANAM, BALASUBRAMANYAM signed 2025-05-19RIPTIDE BIOSCIENCE, INC. VALLEJO, CA71173/227PASDL, file of 2026-10-15
2021-09-21Assignment
Assignment of assignor's interest
JAYNES, JESSE signed 2020-06-09
LOPEZ, HENRY WILFRED signed 2020-04-13
MARTIN, GEORGE R. signed 2020-04-18
YATES, CLAYTON signed 2020-04-20
RIPTIDE BIOSCIENCE, INC. VALLEJO, CA57547/103PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.